The short explanation
For many early breast cancers, removing only the lump with a margin of healthy tissue (breast-conserving surgery) followed by radiotherapy works as well as removing the whole breast (mastectomy) in terms of long-term survival. When doctors offer both, it usually means either is medically reasonable for her. The choice often comes down to personal factors: how she feels about keeping her breast, her worry about recurrence, whether she can attend several weeks of radiotherapy, the size of the tumour compared with the breast, and options for breast reconstruction.
What depends on your situation
The parts of this that change from woman to woman. Uncertainty is stated, not hidden.
- Radiotherapy after lump removal usually involves visits on most weekdays for a few weeks, which can be hard if the centre is far from home. Ask about shorter courses and accommodation near the hospital.
- Some women with a strong family history or a BRCA gene change may lean toward mastectomy. Reconstruction may be possible at the same time or later. It is her decision, and she can take a little time to think and ask for a second opinion.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This cannot tell you which option is best for your sister. Her surgeon can explain how each fits her cancer and situation.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Are both options equally effective for her cancer?
- What would radiotherapy involve, and how far would she need to travel?
- Is reconstruction possible and when?
- Should genetic testing affect her decision?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Get help the same day
- Contact her team the same day after surgery if she has fever, spreading redness or a swelling that keeps growing.
Raise it at a routine appointment
- Book a follow-up discussion with her surgeon before deciding, and bring a list of questions.
Sources
The evidence this explanation is built on.
- Breast cancer MedlinePlus (NIH)
- Breast cancer World Health Organization
- BRCA gene changes: cancer risk and genetic testing National Cancer Institute
Who wrote and reviewed this
Every AskHer answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHer Editorial (AI-assisted) AskHer's editorial team — not an individual clinician Works in English, தமிழ், हिन्दी
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHer’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.

